v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Total Palantir’s Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Net
Accumulated Deficit
AOCI Attributable to Noncontrolling Interest
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023     2,200,128,000          
Beginning balance at Dec. 31, 2023 $ 3,560,965 $ 3,475,561 $ 2,200 $ 9,122,173 $ 801 $ (5,649,613)   $ 85,404
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     20,876,000          
Issuance of common stock from the exercise of stock options 99,870 99,870 $ 21 99,849        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     18,090,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 18 (18)        
Repurchases of common stock (in shares)     (1,155,000)          
Repurchases of common stock (26,699) (26,699) $ (1) (26,698)        
Stock-based compensation 267,872 267,872   267,872        
Other comprehensive income (5,843) (5,736)     (5,736)   $ (107)  
Net income 241,641 239,656       239,656   1,985
Ending balance (in shares) at Jun. 30, 2024     2,237,939,000          
Ending balance at Jun. 30, 2024 4,137,806 4,050,524 $ 2,238 9,463,178 (4,935) (5,409,957)   87,282
Beginning balance (in shares) at Mar. 31, 2024     2,226,963,000          
Beginning balance at Mar. 31, 2024 3,861,172 3,775,227 $ 2,227 9,322,803 (5,720) (5,544,083)   85,945
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     3,394,000          
Issuance of common stock from the exercise of stock options 16,030 16,030 $ 4 16,026        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     8,369,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 8 (8)        
Repurchases of common stock (in shares)     (787,000)          
Repurchases of common stock (17,699) (17,699) $ (1) (17,698)        
Stock-based compensation 142,055 142,055   142,055        
Other comprehensive income 678 785     785   $ (107)  
Net income 135,570 134,126       134,126   1,444
Ending balance (in shares) at Jun. 30, 2024     2,237,939,000          
Ending balance at Jun. 30, 2024 $ 4,137,806 4,050,524 $ 2,238 9,463,178 (4,935) (5,409,957)   87,282
Beginning balance (in shares) at Dec. 31, 2024 2,338,795,000   2,338,795,000          
Beginning balance at Dec. 31, 2024 $ 5,094,407 5,003,275 $ 2,339 10,193,970 (5,611) (5,187,423)   91,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares) 19,102,000   19,102,000          
Issuance of common stock from the exercise of stock options $ 95,201 95,201 $ 19 95,182        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     14,325,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 14 (14)        
Repurchases of common stock (in shares)     (375,000)          
Repurchases of common stock (36,594) (36,594) $ 0 (36,594)        
Stock-based compensation 315,929 315,929   315,929        
Other comprehensive income 10,332 10,332     10,332      
Net income $ 546,289 540,758       540,758   5,531
Ending balance (in shares) at Jun. 30, 2025 2,371,847,000   2,371,847,000          
Ending balance at Jun. 30, 2025 $ 6,025,564 5,928,901 $ 2,372 10,568,473 4,721 (4,646,665)   96,663
Beginning balance (in shares) at Mar. 31, 2025     2,359,663,000          
Beginning balance at Mar. 31, 2025 5,518,973 5,424,155 $ 2,360 10,398,181 (2,994) (4,973,392)   94,818
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     5,528,000          
Issuance of common stock from the exercise of stock options 28,617 28,617 $ 5 28,612        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     6,820,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 7 (7)        
Repurchases of common stock (in shares)     (164,000)          
Repurchases of common stock (18,596) (18,596) $ 0 (18,596)        
Stock-based compensation 160,283 160,283   160,283        
Other comprehensive income 7,715 7,715     7,715      
Net income $ 328,572 326,727       326,727   1,845
Ending balance (in shares) at Jun. 30, 2025 2,371,847,000   2,371,847,000          
Ending balance at Jun. 30, 2025 $ 6,025,564 $ 5,928,901 $ 2,372 $ 10,568,473 $ 4,721 $ (4,646,665)   $ 96,663